EUVIMEDEUVIMED entdecken
Crossref

Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis

Mari Nakanishi iD, Risa Tamagawa-Mineoka iD, Hiromi Nishigaki iD, Yukiyasu Arakawa iD, Satoshi Ohtsuka iD, Norito Katoh iD

Experimental Dermatology · 2025

DOI: 10.1111/exd.70064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Mari Nakanishi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antigens, Differentiation, B-Lymphocyte, Sialic Acid Binding Immunoglobulin-like Lectins, Antigens, CD. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Public Promoting Association Asano Foundation for Studies on Medicine, Japanese Ministry of Education, Science, Sports, and Culture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a common skin disease. Although AD pathogenesis has been widely researched, inhibitory mechanisms in AD are still unclear. Sialic acid‐binding immunoglobulin‐like lectins (Siglecs) are a family of receptors recognising sialic acids; most Siglecs work as inhibitory receptors. Among Siglecs, Siglec‐E is expressed on dendritic cells (DCs) and eosinophils, important immune cells in AD. Although Siglec‐E inhibits Type 1 inflammatory diseases, how it influences AD is unknown. Thus, we investigated the role of Siglec‐E in AD mouse model by using Siglec‐E knockout (KO) mice. We demonstrated that Siglec‐E attenuated AD‐like inflammation of mice caused by topical application of MC903 on ear skin (MC903‐induced AD). To reveal the role of Siglec‐E in MC903‐induced AD, we focused on Siglec‐E on DCs and eosinophils. We first showed that Sigle‐E was expressed on cutaneous DCs and migratory DCs of draining lymph nodes. Moreover, OX40L expression on cutaneous DCs was reduced in the presence of Siglec‐E. In vitro experiments using cultured spleen DCs (SpDCs), highly expressing Siglec‐E, revealed that IL‐33 was involved in the induction of Siglec‐E and confirmed that Siglec‐E inhibited OX40L expression on SpDCs induced by IL‐33. Moreover, CD4 + T cell–SpDC coculture revealed that Siglec‐E inhibited Th2 polarisation under IL‐33 stimulation. We finally revealed that Siglec‐E was expressed on eosinophils and reduced the eosinophils infiltration to the MC903‐treated ear skin with the suppression of CD49d, a necessary integrin for eosinophil migration to skin tissue [1], expression on eosinophils. These findings elucidated the inhibitory role of Siglec‐E in MC903‐induced AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAntigens, Differentiation, B-LymphocyteSialic Acid Binding Immunoglobulin-like LectinsAntigens, CDAnimalsMiceEosinophilsMice, KnockoutDendritic CellsDisease Models, AnimalMice, Inbred C57BLSkinInterleukin-33

Stichwörter der Autor:innen

IL‐33Siglec‐Eatopic dermatitisdendritic cellseosinophils

Substanzen

Siglece protein, mouseAntigens, Differentiation, B-LymphocyteSialic Acid Binding Immunoglobulin-like LectinsAntigens, CDInterleukin-33

Autor:innen und Institutionen

  • Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Laboratory for Experimental Animals, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • North Campus, Kyoto Prefectural University of Medicine, Kyoto, Japan.

ORCID-Profile: Mari Nakanishi, Risa Tamagawa-Mineoka, Hiromi Nishigaki, Yukiyasu Arakawa, Satoshi Ohtsuka, Norito Katoh

Förderung

  • Public Promoting Association Asano Foundation for Studies on Medicine
  • Japanese Ministry of Education, Science, Sports, and Culture

Zitieren

APA

Nakanishi, M., Tamagawa-Mineoka, R., Nishigaki, H., Arakawa, Y., Ohtsuka, S., & Katoh, N. (2025). Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis. Experimental Dermatology. https://doi.org/10.1111/exd.70064

Vancouver

Nakanishi M, Tamagawa-Mineoka R, Nishigaki H, Arakawa Y, Ohtsuka S, Katoh N. Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis. Experimental Dermatology. 2025. doi:10.1111/exd.70064

BibTeX
@article{Nakanishi2025,
  author = {Nakanishi, Mari and Tamagawa-Mineoka, Risa and Nishigaki, Hiromi and Arakawa, Yukiyasu and Ohtsuka, Satoshi and Katoh, Norito},
  title = {Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70064}
}
Kostenlos starten →